Martin S, Pflumio C, Trensz P, Schaff-Wendling F, et al. Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak. Clin Breast Cancer 2022 Oct 13:S1526-8209(22)00228.
PMID: 36414498